TrialAIDS (London, England)2025

Subcutaneous injections of cabotegravir plus rilpivirine long-acting in virally suppressed adults with HIV-1.

Ronald D'Amico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.